HealthThek scale up PercyA broad virtual cancer clinic outside the UK has successfully closed a 4 million dollar fund round, doubled the original € 2 million targets and reached $ 10.4 million funds in total.
These include $ 399k investment from McMillan Cancer Support. Guinness Ventures and Condweight Funds have joined the Octopus Venture and 35 leading oncologist and cancer surgeon in investors in support of the parky health.
“Our mission to close the Cancer Care Gap is driven by an outstanding team who is deeply committed to changing cancer care experience,“Said Kelly McCebbeCo-founder and CEO of Percy Health. “This investment will allow us to advance a model of care that integrates digital innovation with sympathetic, expert-leadership assistance, provides better results for everyone who lives with cancer and beyond itThe “
Founded by two female healthcare inventors in 2020: Kelly McKebbe and Morgan FitzSimons, from Persian Health Prevention to Treatment and Recovery, seem to re -define how cancer is conducted.
As a co-founder and CEO, McKebe brings clinical skills as an expert oncology dietician as a former COO of a network of private cancer facilities. Fitzimons, co-founder and chief customer officer applied its background to the CBS Television and ASOS and its background in consumer experience.
New funds will support company plans to extend its AI-powered, multi-divided virtual cancer clinic, reaching more individuals and healthcare suppliers across the UK.
With a network of over 85 NHS-educated experts, the goal of Persian Health is highly personalized, flexible care that give patients to handle their condition and survive well. Perci integrates digital innovation with human skills to provide support for health approach.
“We are incredibly fascinated by the way Percy Health is dealing with a human-first, technology-capable model with the way of Persian health“Said Cantal Cox Investor in Octopus Venture. “This approach not only addresses the healthcare requirements but also provides measurable effects in both clinical results and cost-skills, which is vital to scales in more insurer, employer and health systemThe “
5% of the directors, 5% of its leadership team and 5% of its executive board are composed of women, Persian Health stands as one of the few scale-ups in the UK with an all-festive founding team. Despite this issue in less than 2% of Venture Capital (according to information provided by the agency), Percy Health has doubled the average contract size for UK’s female-led startups in each of its funds.
“Supporting traders that developed a scaleable, meaningful impact on healthcare is a priority for us“Said Eva-Maria DimitriyadisManaging partner in Condweight Fund. “The innovative, patient-centered model of Percy Health, combined with its view of its leadership and the possibility of growth, is a kind of forward-thought solution to help to grow. As a female -led business, our own – with the majority female investment team – we know that the female founder thinks it is difficult to raise from the VCS statistically. We believe that investing in female founders is not just the right thing, but it gives us access to our exceptional opportunities that others ignore. The 42% of the companies we have invested have at least one female founder and we are thrilled to add Parky Health to that listThe “
McMillan assumes that it is currently almost contained 3.5 million people suffering from cancer in the UK and this number will continue to increaseCreating an urgent need for new, effective ways to support patients.
In the United Kingdom, Cancer results are 25 years behind European colleagues41% of the staged diagnosis contains one In the late stage in England And according to the data provided by Percy Health, critical screening appointments for breast, bowel and uterine cancer are about one third of the missing persons missing.
“We must invent the unique challenges that survive from cancer and to meet the growing needs of people living in and out of it with cancer,“Added Claire TaylorChief Nursing Officer, McMillan Cancer Support. “Persian Health’s universal, multi -divisional methods of the exact exciting innovation that is needed, and it is fully integrated with McMillan’s ambition so that more people help them take personal care they need. This partnership presents a partnership by bringing true differences to people with cancer, helping people to live well and providing suitable solutions to meet their changing needs after cancer experience.“
To improve these results will require cooperation across the government, NHS, private insurance provider, charity and employer and Percy Health, and solve these gaps through a wide care of these gaps, preventing initial detection, treatment on treatment, conducting symptoms and survival care.
“We know that cancer does not stop when treatment is over. In fact, often when people need maximum support. PERCI ensures real personalized care of the AI-powered platform of health, enables accessing the right support at the right time,“Said MorganCo-founder and chief customer officer.
This investment comes when the UK government prioritizes increasingly vocational rehabilitation and reduces the absence of long -term illness “by releasing” with the release “Keep review of Britain’s work“. Persian Health says that they support these goals that are enables to make previous interventions, personalized recovery plans and return-to-work programs that add up to both physical and psychological barriers.
“In Guinness Ventures, we look for founders who are solving meaningful problems in innovative ways,“Said Lisa FoxCo-appointment head, Guinness Ventures. “Persian is doing exactly what one of the largest and best challenges in the care of health cancer care: how do we support humans after the treatment is over. Their model combines with scalpable technology with clinical stiffness, not just for patients, but also provides meaningful results for employers, insurer and broad healthcare ecosystemThe “
“With more people with cancer, health care is an urgent need for solving that provides long -term survival“End McCabeThe “By working with insurers, employers and healthcare suppliers we aim to re -shape cancer care to ensure better results and costs for the systemThe “
[publish_date
